News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Solvay Pharmaceuticals, Inc. Scratches Plan for $300 Million Birmingham Plant
October 1, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Solvay Pharmaceuticals Inc. has scrapped plans to build a $300 million flu drug plant which Birmingham Mayor Larry Langford said was destined for the city.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
MORE ON THIS TOPIC
Manufacturing
Amgen, Sanofi commit nearly $600M to North American expansions
May 6, 2026
·
2 min read
·
Nick Paul Taylor
Earnings
Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales
May 6, 2026
·
4 min read
·
Annalee Armstrong
Business
CellCentric secures $220M in Europe’s biggest private biotech fundraise of 2026
May 6, 2026
·
1 min read
·
Gabrielle Masson
Layoff Tracker
Gilead guts Arcellx team as BioNTech plant closures will wipe out 1,860 jobs
May 6, 2026
·
49 min read
·
BioSpace Editorial Staff
